Agnus Castus Clinical Trials Agnus Castus RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Efficacy of Vitex Agnus-castus BNO 1095 (20 mg) in Women With Primary Dysmenorrhea
Conditions: Primary Dysmenorrhea Interventions: Drug: Vitex agnus-castus BNO 1095 (20 mg); Drug: Placebo Sponsors: Bionorica SE; FGK Clinical Research GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials